Oral Clinical Nutrition Global Market Report 2023: Sector to Reach Grow by Over 5% Annually Through 2033 - ResearchAndMarkets.com

The "Oral Clinical Nutrition Market by Stage, Indication Sales Channel Outlook and by Region - Global Forecast to 2023-2033" report has been added to ResearchAndMarkets.com's offering.

The oral clinical nutrition market size is estimated to be USD 15,358.7 million in 2022 and is expected to witness a CAGR of 5.42% during the forecast period 2023-2033. The rising middle class in emerging nations, the rising frequency of metabolic illnesses, and excessive healthcare costs are some of the factors contributing to market growth. Furthermore, the adult population's growing obesity rate, malnutrition prevalence, and incidence of chronic illnesses including cancer and diabetes are other factors supporting the market growth. However, uncertain perceptions of therapeutic nutrition and a decline in birth rates are anticipated to hinder the market growth.

The rising middle class in emerging nations, the rising frequency of metabolic illnesses, and excessive healthcare costs are expected to fuel the market growth during the projected period. For instance, according to a Gaucher's Institute article published in November 2021, the prevalence of Gaucher illness ranges from 0.70 to 1.75 per 100,000 people globally and affects both men and women equally.

The standardized birth incidence of Gaucher illness in the general population ranges from 0.39 to 5.80 per 100,000 people, according to the same source. clinical nutrition plays a significant role in avoiding harmful effects for patients during procedures and allowing surgeons to operate in a controlled environment. According to data from the Organization for Economic Cooperation and Development revised in August 2022, 94.87, 49.33, 32.84, and 21.5 surgeries (in thousand) were carried out in 2021 in certain European nations, including Portugal, Denmark, Ireland, and Norway.

The adult population's growing obesity rate, malnutrition prevalence, and incidence of chronic illnesses including cancer and diabetes are expected to propel the market growth during the forecast period The need for nutritious food has increased as cancer diagnoses are becoming more common. This is a result of the adverse effects of cancer therapy, which also cause appetite loss and nutritional problems in the adult population, including a loss of vital nutrients like proteins and vitamins. For instance, according to a National Cancer Institute, Columbia, an article from 2018, the number of cancer diagnoses would rise and reach 23.6 million by 2030. The market for oral clinical nutrition will be driven by this. Researchers and scientists are creating methods for creating nutritional items to help cancer patients who suffer from nutritional deficiencies and poor quality of life.

Segmentation

By Stage

The market is categorized into adults and pediatrics. In 2022, the adult segment accounted for the highest revenue share the prevalence of dietary deficiencies and malnutrition in the adult population is to blame for this. The female population of the adult age group is more susceptible to low vitamin levels, apathy, lowered immunity, hypertension, weariness, and calcium deficiencies than the male population. The adult population is thus nutritionally deficient. Oral clinical nutrition products are in higher demand as a result of growing public and professional awareness of the need to address such deficits. According to the NIH study from 2019, for instance, the sale of multivitamin and mineral supplements climbed to 38% among adults in the U.S., generating $55.7 billion in revenue in 2020.

By Indication Outlook

The market is categorized into Alzheimer's, Nutrition Deficiency, Cancer Care, Diabetes, Chronic Kidney Diseases, Orphan Disease, Dysphagia, Pain Management, Malabsorption/GI Disorder/Diarrhea, and Others. In the global market, the cancer care segment accounted for the largest revenue share in 2022 due to the prevalence of genetic illnesses has grown as a result of bad lifestyles, environment, dietary habits, hereditary features, and low immunity. Globally, the incidence of cancer is rising. Modern therapies including chemotherapy and radiation therapy are used in the rise in early cancer detection and treatment of its symptoms. Due to these medications' adverse effects, the patients have low food intake, a decline in body nutrition, and malnutrition.

For patients who lost weight as a result of chemotherapy and other cancer therapies, Esperer Onco Nutrition, for example, introduced Es-Fortitude and Es-Invigour, oral clinical nutrition supplements that may be taken orally. However, Malabsorption/GI Disorder/Diarrhea segment is anticipated to witness the fastest growth during the forecast period. This is attributed to the rising occurrence of these disorders in young children and babies.

The majority of Gastrointestinal problems and malabsorption cases in newborns occur. Thus, there are treatments for oral nutrition on the market to address these symptoms. To meet the escalating demand on the market, the industry participants are stepping up their output. For instance, oral nutrition products used to treat malabsorption, GI problems, FPIES, and eosinophilic esophagitis include Neocate nutrition supplements made by Nutricia such as Neocate- Syneo Baby, Infant DHA/ARA, Nutra, Junior, and Splash.

By Sales channel Outlook

The market is segmented into online sales, retail sales, and institutional sales. In 2022, the institutional sales segment held the largest revenue share. Commercial sales to governmental entities, hospitals, and research facilities are included in the sales channel.

The segment is driven by the increase in patient visits to hospitals, which is caused by the increased prevalence of illnesses and improvements in hospital services. In order to correct vitamin deficiencies, oral supplements given by doctors are the first line of treatment for chronic disorders. However, the online sales segment accounted for the fastest growth during the projected period due to the reduction in travel time and stress, online buying has become comfortable and simple. Due to the growing consumer demand for oral clinical nutrition supplements through online platforms and businesses, there is a growth in online sales. Due to this, the category is expected to increase at a profitable rate throughout the projection period.

Regional Markets

In 2022, the North American region accounted for the highest revenue in the oral clinical nutrition market and is expected to maintain its dominance during the forecast period.

It is anticipated that the rising prevalence of non-communicable illnesses in this region, such as cancer, diabetes, hypertension, and CKDs, would increase the demand for oral clinical nutritional products. The industry is expanding as a result of growing attempts by food and nutrition corporations and pharmaceutical firms to diversify their product lines.

The Asia Pacific region is anticipated to experience the fastest growth rate throughout the forecast period due to expanding healthcare facilities, improved healthcare reimbursement policies, government efforts in the healthcare sectors, and greater economic growth, all of which help to drive the market's expansion. One of the primary elements promoting regional growth is the presence of important players in this area.

Key Topics Covered:

1. Research Methodology

2. Introduction: Oral Clinical Nutrition

3. Executive Summary

4. Market Dynamics

5. Market Environment Analysis

6. COVID-19 Impact Analysis: Oral Clinical Nutrition Market

7. Market Analysis by Stage

8. Market Analysis by Indication Outlook

9. Market Analysis by Sales Channel Outlook

9 Regional Market Analysis

10 North America Oral Clinical Nutrition market

11. Europe Oral Clinical Nutrition market

12. Asia PacificOral Clinical Nutrition Market

13. Latin America Oral Clinical Nutrition market

14. MEA Oral Clinical Nutrition Market

15. Competitor Analysis

16. Company Profiles

17. Conclusion & Recommendations

A selection of companies mentioned in this report includes

• Abbott Laboratories
• Danone Nutricia
• Victus Inc
• Otsuka Holdings Co. Ltd.
• Baxter International Inc.
• Mead Johnson & Company LLC
• Bayer AG
• Nestle S.A.
• GlaxoSmithKline plc
• Pfizer.

For more information about this report visit https://www.researchandmarkets.com/r/va3y22

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230327005566/en/